Sanofi (SNY) Sales of Property, Plant and Equipment (2009 - 2026)
Powered by 
Analysis
Sanofi (SNY) Sales of Property, Plant and Equipment (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 63.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 26.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 363.82 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 5.85 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 363.82 Mn |
| Mar 31, 2026 | 129.95 Mn |
| Dec 31, 2025 | 372.49 Mn |
| Sep 30, 2025 | 108.72 Mn |
| Jun 30, 2025 | 101.88 Mn |
| Mar 31, 2025 | 361.85 Mn |
| Dec 31, 2024 | 860.22 Mn |
| Sep 30, 2024 | 163.63 Mn |
| Jun 30, 2024 | 91.54 Mn |
| Mar 31, 2024 | 468.22 Mn |
| Dec 31, 2023 | 848.92 Mn |
| Sep 30, 2023 | 263.44 Mn |
| Jun 30, 2023 | 185.12 Mn |
| Mar 31, 2023 | 437.92 Mn |
| Dec 31, 2022 | 756.00 Mn |
| Jun 30, 2022 | 210.21 Mn |
| Mar 31, 2022 | 389.45 Mn |
| Jun 30, 2021 | 261.33 Mn |
| Mar 31, 2021 | 98.91 Mn |
| Jun 30, 2020 | 257.74 Mn |